Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma

References

Page 1

	Year	Citations
Cancer statistics, 2012 Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal CA A Cancer Journal for Clinicians	2012	10.7K
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells Maria Ho, Alvin V. Ng, Stephen Lam, Cancer Research PathologyCancer BiologyStem-like Cancer CellsTumor BiologyTumor Heterogeneity	2007	944
Highly tumorigenic lung cancer CD133 <sup>+</sup> cells display stem-like features and are spared by cisplatin treatment Giulia Bertolini, Luca Roz, Paola Perego, Proceedings of the National Academy of Sciences Normal Lung TissuePathologyCancer BiologyTumor BiologyCisplatin Treatment	2009	775
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis Wen Cai Zhang, Ng Shyh‐Chang, Yang He, Cell Glycine Decarboxylase ActivityOncogenic AgentMedicineTumor SuppressorRadiation Oncology	2012	666
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells Julie Mathieu, Zhan Zhang, Wenyu Zhou, Cancer Research Stem Cell BiologyCancer BiologyTumor BiologyTranscriptional RegulationCancer Cell Biology	2011	507
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies Yin Wang, Yan Liu, Sami N. Malek, Cell stem cell MedicineCancer Cell BiologyTumor SuppressorHematological MalignanciesCancer Biology	2011	402
The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion Mei Yee Koh, Robert Lemos, Xiuping Liu, Cancer Research Acute HypoxiaAggressive Tumor GrowthCancer BiologyRedox BiologyTumor Biology	2011	347
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene Xianrang Song, Xianxi Liu, Weiling Chi, Cancer Chemotherapy and Pharmacology Tumor BiologyHif-1α GeneOncologyMedicineCancer Cell Biology	2006	252
Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties Jing Wang, Fei Lu, Qi Ren, Cancer Research Histone ModificationsHistone H3k4 MethylationEpigenetic ChangeLsd1 ExpressionCancer Biology	2011	228
Targeting cancer stem cells: a new therapy to cure cancer patients. Ya-Peng Hu, Liwu Fu PubMed Cell TherapyCancer Stem CellAdult Stem CellCancer PatientsStem Cell Biology	2012	192

Page 1